首页 | 本学科首页   官方微博 | 高级检索  
     

HPLC测定重组Exendin-4-FC融合蛋白注射液中抗氧剂及其降解物
引用本文:鹿泽华,冀苏龙,刘帅虎,王力,高彦,申志强,李景艳,王斌. HPLC测定重组Exendin-4-FC融合蛋白注射液中抗氧剂及其降解物[J]. 中国现代应用药学, 2024, 41(1): 112-118
作者姓名:鹿泽华  冀苏龙  刘帅虎  王力  高彦  申志强  李景艳  王斌
作者单位:河南晟明生物技术研究院有限公司,河南 新乡 453000;华兰生物基因工程有限公司,河南 新乡 453000
摘    要:目的 建立HPLC对重组Exendin-4-FC融合蛋白注射液中11种抗氧剂及其降解物含量测定方法。方法 采用饱和硫酸铵沉淀蛋白,离心后上清液转移至经甲醇活化后的C18固相萃取小柱中,分别用4 mL甲醇、5 mL乙酸乙酯依次洗脱小柱,洗脱液用甲醇-乙酸乙酯(2∶3)混合溶剂定容后过0.22μm PTFE疏水滤膜,经HPLC分析,外标法定量。色谱条件:Kinetex?XB-C18 100?(100 mm×4.6 mm,2.6μm)色谱柱,检测波长230 nm,柱温箱30℃,进样量5μL,流速0.4 mL·min–1,流动相0.1%甲酸-甲醇(A)-0.1%甲酸水溶液(B),运行时间45 min。结果 11种目标物在2.5~35μg·mL–1内线性关系良好(R2≥0.99)。在25,10,5μg·mL–1 3个浓度水平下,平均加样回收率为88.1%~106.5%,RSD为0.10%~9.05%。6份样品重复性RSD为2.01%~4.77%...

关 键 词:重组Exendin-4-FC融合蛋白注射液  抗氧剂  高效液相色谱法
收稿时间:2022-11-09

Determination of Antioxidants and Their Degradation Products in Recombinant Exendin-4-FC Fusion Protein Injection by HPLC
LU Zehu,JI Sulong,LIU Shuaihu,WANG Li,GAO Yan,SHEN Zhiqiang,LI Jingyan,WANG Bin. Determination of Antioxidants and Their Degradation Products in Recombinant Exendin-4-FC Fusion Protein Injection by HPLC[J]. The Chinese Journal of Modern Applied Pharmacy, 2024, 41(1): 112-118
Authors:LU Zehu  JI Sulong  LIU Shuaihu  WANG Li  GAO Yan  SHEN Zhiqiang  LI Jingyan  WANG Bin
Affiliation:Henan Shengming Biotechnology Research Co., Ltd., Xinxiang 453000, China;Hualan Genetic Engineering Co., Ltd., Xinxiang 453000, China
Abstract:OBJECTIVE To establish a method for determining the content of 11 antioxidants and their degradation products in recombinant Exendin-4-FC fusion protein injection by HPLC. METHODS The protein was precipitated with saturated ammonium sulfate. After centrifugation, the supernatant was transferred to a C18 solid phase extraction cartridge activated by methanol. Then the cartridge was eluted with 4 mL of methanol and 5 mL of ethyl acetate respectively, and the eluent was diluted with methanol-ethyl acetate(2∶3) mixed solvent and passed through a 0.22 μm PTFE hydrophobic filter. It was analyzed by HPLC and quantified by external standard method. Chromatographic conditions: Kinetex® XB-C18 100Å (100 mm×4.6 mm, 2.6 μm)column, the detection wavelength was 230 nm, the column oven was 30 ℃, the injection volume was 5 μL and the flow rate was 0.4 mL·min–1, mobile phase was 0.1% formic acid-methanol(A)-0.1% formic acid aqueous solution(B), the running time was 45 min. RESULTS The 11 target substances showed a good linear relationship in the range of 2.5-35 μg·mL–1 with R2 ≥0.99. At three different concentration(25, 10, 5 μg·mL–1) of spiked samples, the average recovery rates of 11 antioxidants ranged from 88.1% to 106.5%, with RSDs in the range of 0.10%–9.05%. The RSDs of 6 repeatable samples was 2.01%–4.77%, which of 12 intermediate precision samples was 2.58%–9.75%. The positive/inverted samples of three batches of recombinant Exendin-4-FC fusion protein injection were detected at 0 month, 3 months and 6 months(25 ℃), and the results showed that there was no antioxidant and its degradation leaching in all batches of samples at different detection points. CONCLUSION The method has good specificity, high accuracy and precision, good solution stability, high durability and can be used for the content detection of antioxidants in drugs.
Keywords:recombinant Exendin-4-FC fusion protein injection  antioxidants  HPLC
点击此处可从《中国现代应用药学》浏览原始摘要信息
点击此处可从《中国现代应用药学》下载免费的PDF全文
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号